key: cord-0711200-6anae815
authors: Mathews, Simon; Natarajan, Yamini; Sofia, Anthony; Patel, Amit; Francis, Dawn; Streett, Sarah; Siddique, Shazia
title: Development of AGA’s policy agenda during the COVID-19 pandemic
date: 2021-05-11
journal: Gastroenterology
DOI: 10.1053/j.gastro.2021.04.076
sha: 5b6613c88675baa15a3e546135626e6f38795706
doc_id: 711200
cord_uid: 6anae815

nan

The unprecedented coronavirus pandemic (COVID-19) disrupted the healthcare community. In response, the American Gastroenterological Association (AGA) adapted and expanded its policy priorities to meet the evolving needs of members and patients. To inform these efforts, the AGA launched a needs assessment survey to better understand the impact of COVID-19 on gastroenterology and hepatology (GI) providers in clinical practice. The findings were leveraged to develop timely resources for the GI community, inform advocacy efforts, and advance a robust legislative agenda that resulted in support for COVID-19-related legislative and regulatory protections for the GI community.

Here, we summarize the survey findings and describe the AGA's programmatic responses to the COVID-19 pandemic, focusing on its advocacy and legislative efforts. Further, we share how these experiences continue to actively inform ongoing support for the GI community during COVID-19, including vaccine administration. Finally, we discuss how these experiences with COVID-19 help provide a model for rapid assessment and targeted response for future public health crises.

The AGA developed and distributed the COVID-19 Needs Assessment survey during July and August of 2020 via email to the AGA membership. We assessed a range of topics that included feedback on providers' experiences with resumption of elective procedures, growth and implementation of telehealth, access to personal protective equipment (PPE), impacts of COVID-19 on financial feasibility and security, and utilization of governmental COVID-19 relief programs. In total, there were 432 respondents and response rates to individual questions varied. Of those who reported practice type, forty percent were in single-specialty practice, 33% in academic practice, 13% in hospital-based practice, and 12% in multi-specialty group practice.

When respondents were asked about the impacts on their GI practices without substantive future federal grants and loans, 42% of the 313 respondents indicated their practices would be" smaller (than pre-COVID-19 levels) and financially unhealthy." Respondents also indicated utilization of several COVID-19-related financial assistance programs. The applications and receipts of aid for different programs are depicted in Figure 1 . Thirty-five percent of respondents did not apply for any federal grants, loans, or funds.

A majority of respondents were concerned about reduced procedure volume upon resuming elective endoscopy. Of 358 respondents, over 95% of respondents predicted a return to lower endoscopic volume than baseline, prior to COVID. Moreover, a quarter of respondents predicted that a return to pre-COVID-19 levels would take more than 12 months.

There were 352 respondents who answered questions relating to management of PPE resources. They rated a significant degree of difficulty (responses of "Extremely difficult," "Very Difficult," or "Difficult") across the following PPE-related challenges: Utilization Rates (57%), Sourcing (55%), Regulatory/External Interventions (38%), and Staff Compliance/Adherence (24%). These respondents cited using multiple approaches for PPE conservation that included re-use tactics (72%), staff education (70%), increased inventory security (52%), and policy changes (39%). When asked how PPE resources compared to the two weeks prior to the survey, the majority (62%) noted "no change", with 18% indicating "worse" (resources continue to decline) and 20% indicating "better" (some PPE needs addressed).

Utilization and type of telemedicine services varied. Respondents noted using the following options for the majority of their telemedicine visits (multiple responses possible): electronic health record (EHR)-integrated (26%), non-EHR integrated (27%), patient registration-based (19%), commercial CMS-allowed third-party (such as Zoom or Skype, 18%), audio-only (18%), or asynchronous (i.e., online patient portal or email, 11%).

Respondents cited multiple barriers that contributed to limited utilization of telemedicine. When asked about converting in-person to telemedicine visits, 324 respondents indicated significant difficulty ("Extremely difficult," "Very difficult," or "Difficult") related to commercial payor reimbursement (53%), patient engagement/interest and ability to participate (50%), technology or equipment (48%), Medicare reimbursement (45%), and interstate regulations on healthcare delivery (39%).

In response to the COVID-19 pandemic, the AGA spearheaded several initiatives to address the immediate needs of gastroenterologists. First, members of the Clinical Guidelines Committee and the Clinical Practice Update Committees convened to form the Rapid Review Working Group for COVID-19 in order to develop evidence-based recommendations to guide use of PPE and pre-procedure COVID-19 testing for endoscopic procedures. [1] [2] [3] The AGA utilized rigorous GRADE methodology and systematic reviews to state a much stronger position to show the potential benefits and harms of policies on patient care. This allowed the AGA to leverage the working group's guidance to advocate more effectively for resources on Capitol Hill.

Second, the AGA leveraged virtual member outreach to better understand the concerns and barriers for gastroenterology practices and members impacted by the pandemic. These most frequently took the form of Presidential Townhalls where AGA leaders engaged members to hear about their challenges with practice finances, resumption of endoscopy, and timely provision of patient care. These stories provided our members of Congress with concrete examples of how their constituents were affected by the pandemic and further supported our request for additional resources.

Third, the AGA advanced existing gastroenterology advocacy priorities within COVID-19 advocacy efforts. One such effort succeeded in the incorporation of legislation to close the Medicare colonoscopy loophole within COVID-19 relief legislation. The fix to the loophole will be implemented in 2022 and will gradually phase-out the coinsurance for Medicare beneficiaries by 2030. AGA also advocated for HR 7077/S. 3877, the Community Solutions for COVID-19 Act, to improve access to testing and treatment for minority communities that have been disproportionately impacted by the pandemic. This legislation aligned with the AGA's Equity J o u r n a l P r e -p r o o f Project, a broader multi-year effort to use advocacy to eliminate health disparities in GI care. 4 While this bill was not specific to gastroenterology, it was an important step toward reducing health disparities for our patients and improving overall patient care.

Impact of COVID-19 on Advocacy AGA members increased their engagement as a result of the organization's focus on pandemicrelated policy. Through the online AGA Advocacy Center, members sent a record number of letters to their members of Congress: 1,296 letters by 364 members regarding reimbursement cuts and 3,047 letters by 944 members regarding COVID-19 relief. The outreach made by AGA members was instrumental to achieving success in our legislative endeavors.

The response to COVID-19 also bolstered existing advocacy programs, including 84% growth in the AGA Congressional Advocates Program (CAP). The CAP was re-established in 2018 and is a grassroots civic engagement program for AGA members to learn about GI-related advocacy, engage with their peers, and foster relationships with local representatives. In addition, AGA's September Advocacy Day went virtual in 2020leading to a record turnout of 75 members conducting 76 meetings with members of Congress from 26 states. Similarly, a record number of AGA members joined cardiologists, rheumatologists and other specialists in the Alliance of Subspecialty Medicine's Virtual Advocacy Day in November 2020. Lastly, AGA members also increased engagement via the AGA political action committee (PAC). AGA PAC is the voluntary bipartisan political arm of AGA and the only PAC dedicated to gastroenterology, supporting candidates who align with our public policy priorities such as access to care, fair reimbursement and NIH research.

The AGA supported a number of legislative and regulatory initiatives in 2020, directly addressing COVID-19 and continuing to support ongoing GI priorities.

The Legislative Agenda related to the COVID-19 pandemic is shown in Table 1 . Efforts included supporting CMS' payment parity for audio-only telehealth visits, supporting H.R.6720 -the Student Loan Forgiveness for Frontline Health Workers Act, and delaying the proposed 5% cut to Medicare physician payments for 2021. The AGA championed the Removing Barriers to Colorectal Cancer Screening Act which removed the cost-sharing burden associated with polypectomy during screening colonoscopy and was ultimately incorporated within the successful passing of the Consolidated Appropriations Act. The AGA continued advocacy for the successful increase in federal funding for GI research at the National Institutes of Health and the Department of Defense. It also supported reform of the Stark Law and Antikickback Statute at HHS and reform of the prior authorization process by assisting in the introduction of bills in both the U.S. House and Senate.

The AGA Government Affairs committee continues to work closely with AGA members on how best to support the pandemic response and recovery efforts. For example, the AGA endorses the Building COVID-19 Vaccine Confidence Act and the COVID-19 Prevention and Awareness Act of 2021. These bills fund vaccine promotion efforts among vulnerable populations and those at increased risk for COVID-19-related complications, including people with liver disease or those using immune modifying medications.

The new year and presidential administration have wrought several changes that the AGA continues to track. These include a new open enrollment period for health insurance exchanges to support people who are uninsured or have lost employer-sponsored coverage and extending regulations allowing telehealth services for all Medicare patients. The AGA supports efforts to make access to vital care and technology services permanently available for patients and practices. Later this year, the Supreme Court is expected to rule on whether the Affordable Care Act remains constitutional. The AGA will advocate for legal provisions to ensure access to specialty care, colon cancer screening, and protections for people with pre-existing conditions. Lastly, the AGA will support programs anticipated in the next stimulus package that support small businesses that have benefited AGA members previously.

The public health emergency has prompted the AGA to re-evaluate its processes and develop new methods to rapidly meet the needs of its members. This adaptability is important to codify for future crises, which could similarly result in major changes in the healthcare landscape and pose a significant threat to gastroenterology practices and care of digestive disease patients. The lessons learned from the COVID-19 experience to date have demonstrated the importance of the key steps below which are also summarized in Figure 2 :

1. Conduct members needs' assessments: These should be performed routinely and iteratively. They can take the form of membership surveys that allow for quantitative analysis, as well as open discussion on the AGA Community or during webinars and Townhalls for more qualitative and narrative feedback. As public health emergencies evolve, the concerns and needs of our members will change, so it is important for assessments to be conducted on an ongoing basis. This will allow us to ensure that advocacy efforts and legislative development remain on pace with members' needs. 2. Employ a collaborative approach: As new areas of interest emerge within the AGA in response to evolving crises, working groups and task forces will emerge to address new areas of interest. Advocacy efforts should leverage developing AGA efforts to work collaboratively on legislative action items that can improve patient care. Similarly, a collaborative approach with other specialties who face similar barriers to practice is important. The AGA's close relationship with sister GI societies, physician organizations, and other health advocacy groups, remain vital in staying up to date on the latest movements on Capitol Hill and provide opportunities to execute on shared priorities. 3. Engage members in advocacy: Members of Congress are much more likely to take action on legislation if a constituent meets with them or contacts them directly. When urgent legislative action is needed, the AGA should continue to leverage engaged members through the Congressional Advocates Program and other existing infrastructure, including Advocacy Day and the PAC.

To initially address the COVID-19 pandemic, the AGA adjusted its priorities based on both datadriven and qualitative feedback from its members. This resulted in the development of pragmatic clinical resources, increased member engagement through virtual technology, and the advancement of new and existing advocacy priorities. In addition, by continuing to strengthen member-based advocacy, the AGA helped secure tangible COVID-19 and GIfocused legislative and regulatory successes. Because the COVID-19 pandemic continues to present challenges for GI physicians and their patients, the AGA is committed to continuing its engagement of its members for input, collaboration with other key stakeholders, and support of advocacy efforts. We are optimistic that by continuing to iterate on this approach, the AGA will continue to support its members and the patients they serve in any future disruptions in care. 

AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy